http://shop.advanceweb.com/scrubs.html/?utm_source=laboratorian.advanceweb&utm_medium=banner&utm_content=leaderboard&utm_campaign=SCRUBS213

Free Subscription & E-newsletter

News Watch

Year: Display by: Sort
May 2013
Aviir Launches Complete Cardiovascular Genetic Testing

Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, will be extending its offered services with comprehensive inherited cardiovascular disease genetic test menu.The newly ...

Posted on: May 22, 2013
CAP Offers First Evidence-Based Guideline for Validating Whole Slide Imaging

The College of American Pathologists (CAP) has released a new evidence-based guideline, "Validating Whole Slide Imaging for Diagnostic Purposes in Pathology."  The guideline is the first of its kind and is now available in the CAP's peer-reviewed ...

Posted on: May 21, 2013
Study Establishes Basis for Genomic Classification of Endometrial Cancers

A comprehensive genomic analysis of nearly 400 endometrial tumors suggests that certain molecular characteristics - such as the frequency of mutations - could complement current pathology methods and help distinguish between principal types of ...

Posted on: May 20, 2013
Decades of Improving Cholesterol Levels Abruptly Ended in 2008, Study Finds

Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study published in PLOS ONE.The study, by researchers at Quest ...

Posted on: May 19, 2013
New Device Can Extract Human DNA with Full Genetic Data in Minutes

Take a swab of saliva from your mouth and within minutes your DNA could be ready for analysis and genome sequencing with the help of a new device.University of Washington engineers and NanoFacture, a Bellevue, Wash., company, have created a device that ...

Posted on: May 18, 2013
New Test for H7N9 Bird Flu in China May Help Slow Outbreak, Prevent Pandemic

Breaking research appearing online in Clinical Chemistry, the journal of AACC, demonstrates that a recently developed diagnostic test can detect the new strain of influenza (H7N9) currently causing an outbreak in China.Since the end of March, ...

Posted on: May 17, 2013
DiaSorin Gets FDA Clearance for LIAISON Aldosterone Assay

DiaSorin Inc. has received FDA clearance for their LIAISON Aldosterone immunoassay.  It is intended for the quantitative determination of Aldosterone in human serum, EDTA plasma and urine samples.Aldosterone is a mineralocorticoid hormone ...

Posted on: May 16, 2013
Professional Societies Delineate Concerns, Offer Recommendations Regarding Interim Pricing for Molecular Tests

A coalition representing over 120,000 medical and laboratory professionals and institutions that perform the vast majority of clinical molecular pathology testing in the United States released a joint statement Monday regarding new Medicare ...

Posted on: May 15, 2013
Stronger Together: Advanced Interoperability of Aperio Epathology and Leica Biosystems Solutions

Following the acquisition of Aperio, Leica Biosystems announced  two software releases facilitating interoperability throughout the combined Aperio ePathology portfolio.Digital pathology users can now utilize images created on any of the ScanScope, ...

Posted on: May 15, 2013
Targeted Screening for C. difficile Upon Hospital Admission Could Potentially Identify Most Colonized Patients

Testing patients with just three risk factors upon hospital admission has potential to identify nearly three out of four asymptomatic carriers of C. difficile, according to a new study published in the May issue of the American ...

Posted on: May 14, 2013
NovoPath Marks 20 Years of Anatomic Pathology Market Success

NovoPath this month marks its 20th year of delivering management and reporting software solutions to anatomic pathology (AP) providers, after experiencing double-digit growth in 2012, a year marked by far-reaching business challenges.  Recognized ...

Posted on: May 13, 2013
Blood Sample Predicts if Cancer Patients Respond to Therapy

Karolinska Institutet and University Hospital have shown that a simple blood test canpredict breast cancer patients' response to therapy, how long treatment will be effectiveand survival. The results were being presented at the recent IMPAKT ...

Posted on: May 11, 2013
Blood Sample Predicts if Cancer Patients Respond to Therapy

Karolinska Institutet and University Hospital have shown that a simple blood test canpredict breast cancer patients' response to therapy, how long treatment will be effectiveand survival. The results were being presented at the recent IMPAKT ...

Posted on: May 11, 2013
Researchers Pinpoint Upper Safe Limit of Vitamin D Blood Levels

Researchers claim to have calculated for the first time, the upper safe limit of vitamin D levels, above which the associated risk for cardiovascular events or death raises significantly, according to a recent study accepted for publication in The ...

Posted on: May 10, 2013
Johns Hopkins Pathology Joins PathCentral Digital Pathology Network

PathCentral, a technology-enabled company dedicated to the success of the international pathology community, today announced that the Johns Hopkins University School of Medicine's department of pathology will participate as a client in the PathCentral ...

Posted on: May 09, 2013
Hillary Rodham Clinton to Keynote ASCP 2013

Hillary Rodham Clinton, former Secretary of State and former U.S. Senator from New York will be the keynote speaker at the American Society for Clinical Pathology (ASCP) 2013 Annual Meeting on Wednesday, Sept. 18, from 6 to 7:30 p.m. in Chicago.Secretary ...

Posted on: May 08, 2013
Sunquest Laboratory Receives 2014 ONC HIT Certification

Sunquest Laboratory Receives 2014 ONC HIT Certification Sunquest Information Systems announced today that Sunquest Laboratory version 7.0.1003 is compliant with the ONC 2014 Edition criteria and was certified as an EHR Module on April 24 by the ...

Posted on: May 07, 2013
Retrospective Study Suggests that Patients with Lung Cancer who Carry Specific HER2 Mutations May Benefit from Certain ...

New results from a retrospective study conducted in Europe suggest that anti-HER2 treatments, like the widely used breast cancer agent trastuzumab (Herceptin), have anti-cancer effects in a small subset of patients with advanced non-small cell lung ...

Posted on: May 06, 2013
ASPYRA Announces CyberLAB 7.2.11 with Features to Improve LIS Ordering and Results Delivery

ASPYRA, LLC (ASPYRA) announced that the newest release of their browser-based Laboratory Information System (LIS) CyberLAB provides an enhanced rapid-order entry workflow option that can streamline order processing. In addition, an e-mail results ...

Posted on: May 05, 2013
ZEISS Lightsheet Z.1 Named Best New Life Science Product of 2012

At the American Association for Cancer Research (AACR) Annual Meeting 2013 in Washington, DC, SelectScience announced that ZEISS Lightsheet Z.1 has been awarded with the Best New Life Science Product of 2012 honors ...

Posted on: May 04, 2013
Abbott Introduces mPlus to Further Automate Its RealTime m2000 Molecular Diagnostics System

Abbott has introduced a new capability for its RealTime m2000 system to enhance the system's flexibility and make molecular testing easier and more efficient for laboratories. Abbott's new mPlus makes it possible for laboratories of any size to ...

Posted on: May 03, 2013
Study Shows Potential New Way to Detect Colorectal and Other Cancers

A unique new study led by University of Kentucky Markey Cancer Center researchers Guo-Min Li and Libya Gu, in collaboration with Dr. Wei Yang at National Institutes of Health, reveals a novel mechanism explaining the previously unknown root cause of some ...

Posted on: May 02, 2013
Life Technologies' Instruments FDA-Cleared Under Emergency Use Authorization for Avian Flu Virus Screening

Life Technologies Corporation  announced that its Applied Biosystems 7500 Fast Dx Real-Time PCR instrument is the sole platform cleared for use under the CDC protocol created for emergency screenings of patients suspected of harbouring the ...

Posted on: May 01, 2013
April 2013
New Abbott Test Helps Detect Presence of Two Health Issues

Abbott has announced that the ARCHITECT AFP test, which may help doctors detect serious birth defects and the progression of testicular cancer, recently received U.S. Food and Drug Administration (FDA) approval. Biomarkers, such as alpha-fetoprotein ...

Posted on: April 30, 2013
EKF Diagnostics Launches MDx/CDx Division

EKF Diagnostics, worldwide manufacturer of point-of-care diagnostic tools, organ injury biomarkers and assays, has announced the launch of a new division to focus on molecular and companion diagnostics. EKF Molecular Diagnostics will develop ...

Posted on: April 29, 2013
Rheonix Expands Intellectual Property Portfolio with U.S. Patent for a Fully Automated Molecular Platform

Rheonix Inc., the developer of automated molecular diagnostic testing platforms, has been issued a patent protecting self-contained instruments for purifying, amplifying, and analyzing one or more target nucleic acid sequences necessary for performing a ...

Posted on: April 28, 2013
Next-Generation Circulating Tumor Cell Test Demonstrates High Efficiency and Accuracy in New Study

Veridex has announced that the first study of the company's next-generation circulating tumor cell (CTC) technology, developed in collaboration with researchers at Massachusetts General Hospital (MGH), has been published in Science Translational ...

Posted on: April 27, 2013
Genomic Health to Address One of the Most Significant Needs in Men's Health with the Oncotype DX Prostate Cancer Test

Genomic Health to  Make Oncotype DX Prostate Cancer Test Available to Physicians and  Patients by End of Second QuarterGenomic Health has announced that the clinical trial results validating its biopsy-based Oncotype DX prostate cancer test ...

Posted on: April 26, 2013
Beckman Coulter Receives FDA Clearance on Next Generation Hemoglobin A1c Test

Beckman Coulter has received U.S. Food and Drug Administration (FDA) clearance on a new Hemoglobin A1c assay  (HbA1c-) with improved performance for standard use on the company's UniCel DxC Systems.The HbA1c- reagent has been designed and developed ...

Posted on: April 25, 2013
Use and Advantages of PCT-based Sample Preparation Methods Highlighted in Studies of Cancer, Stem Cell, and Heart Disease ...

Pressure BioSciences Inc. has announced that scientists from three separate research groups presented data at the recent US HUPO 9th annual Conference, Baltimore, indicating that sample preparation methods based on the company's patented pressure cycling ...

Posted on: April 24, 2013
Quest Diagnostics Launches Novel Rheumatoid Arthritis Tests

Quest Diagnostics announced the availability of two new blood tests for aiding the early diagnosis of arthritis (RA), an autoimmune disorder that can cause debilitating joint damage.The lab-developed tests are based on the proprietary 14-3-3eta protein ...

Posted on: April 23, 2013
HTG Molecular Diagnostics Edge System a Finalist for Medical Design Excellence Award

The Edge System, developed by HTG Molecular Diagnostics, is a finalist in the 15th annual Medical Design Excellence Awards competition. HTG Molecular Diagnostics is a privately held company specializing in RNA based diagnostics and solutions for ...

Posted on: April 22, 2013
New Cyanine Dyes Reduce Time and Cost of Oligo Labelling

Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent manufacturer, has launched a range of high quality cyanine dye products to support the continued increase in demand for fluorescent labelling in biological imaging and ...

Posted on: April 20, 2013
BD MAX Cdiff Assay Receives FDA Clearance

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a global medical technology company, has received FDA clearance to market the BD MAX Cdiff Assay in the United States. The assay is performed on the fully-automated BD MAX System and ...

Posted on: April 19, 2013
Leica Biosystems Launches the EXPERIENCELAB Tour

Leica Biosystems announced the launch of the EXPERIENCELAB tour, a mobile demonstration lab that showcases Leica's full line of anatomical pathology solutions. Customers will be able to visit the EXPERIENCELAB as it moves across North America. This will ...

Posted on: April 19, 2013
Meridian Bioscience Announces illumigene® Group A Streptococcus and illumigene® Group B Streptococcus Tests

Meridian Bioscience Inc. announced the U.S. Food & Drug Administration (FDA) has re-categorized Meridian's illumigene® Group A Streptococcus and illumigene® Group B Streptococcus tests as "Moderate Complexity" under the Clinical Laboratory ...

Posted on: April 19, 2013
A New Protein Target for Controlling Diabetes

Researchers at the University of California, San Diego School of Medicine have identified a previously unknown biological mechanism involved in the regulation of pancreatic islet beta cells, whose role is to produce and release insulin. The discovery ...

Posted on: April 18, 2013
Study Finds Corus CAD to Be More Accurate in Excluding the Diagnosis of Obstructive Coronary Artery Disease in Women than ...

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, has announced data demonstrating that Corus CAD, the only clinically validated gene expression test for the assessment of obstructive coronary artery disease (CAD), has higher ...

Posted on: April 17, 2013
'Comparison Shopping' for Lab Tests by Doctors Saves Money

Research at Johns Hopkins suggests that if hospitals would show physicians the price of some diagnostic laboratory tests at the time the tests are ordered, doctors would order substantially fewer of them or search for lower-priced alternatives. In a ...

Posted on: April 16, 2013
Scientists Make iPhone into Low-cost Microscope to Diagnose Intestinal Worm Infections in African Children

Scientists working in rural Tanzania have used a simple $8 glass lens, a strip of double-sided tape, and a cheap flashlight to convert an Apple iPhone into a field microscope that can successfully detect intestinal worm infections in children, according ...

Posted on: April 16, 2013
ImageView Offers Complete Document and File Archive System for Clinical and Pathology Labs

Blue River Systems announced that an update to its ImageView for Clinical Labs suite of solutions for capturing, storing and accessing electronic files is now available. The solution ensures immediate access to requisitions, EOB's and other source ...

Posted on: April 15, 2013
Laboratory Guide to Workplace Safety (NZ) 2013 Released

Pro-Visual Publishing announces its inaugural release of the 2013 Laboratory Guide to Workplace Safety (NZ). In conjunction with Science Industry Australia (SIA) and the Australasian Laboratory Managers Association (ALMA), Pro-Visual delivers this guide, ...

Posted on: April 14, 2013
Lipid Remnants Measured by VAP Lipid Panel Associated with 28% Increase in Heart Attack Events in Study Population

Researchers investigating heart disease in African Americans presented findings this month showing that increased levels of remnant lipoprotein cholesterol measured with Atherotech Diagnostics Lab's VAP Lipid Panel were a significant, ...

Posted on: April 13, 2013
Disease Knowledge May Advance Faster with CRISPR Gene Probing Tool

Scientists at UC San Francisco have found a more precise way to turn off genes, a finding that will speed research discoveries and biotech advances and may eventually prove useful in reprogramming cells to regenerate organs and tissues.The strategy ...

Posted on: April 12, 2013
Study Finds Saliva Testing Predicts Aggression In Boys

A new study indicates that a simple saliva test could be an effective tool in predicting violent behavior. The pilot study, led by Cincinnati Children's Hospital Medical Center and published this week online in the journal Psychiatric Quarterly, suggests ...

Posted on: April 11, 2013
Study: New Genetic Test Better Predicts Mother's Risk of

Asuragen Inc., a molecular diagnostics company, has announced results from a study demonstrating that a new molecular test called Xpansion Interpreter can improve the determination of a woman's risk of having a child with fragile X syndrome, the most ...

Posted on: April 10, 2013
Streamlining PCR Assay Design with IDT PrimerQuest Design Tool

Integrated DNA Technologies (IDT), a leader in oligonucleotide synthesis, launches a new and enhanced version of the open access PrimerQuest online tool, for efficient PCR primer and probe design. Selection parameters have been optimized ...

Posted on: April 09, 2013
Gold Standard Diagnostics Expands ThunderBolt Laboratory Automation Platform International Sales and Marketing

Gold Standard Diagnostics, manufacturer and marketer of clinical laboratory instrumentation and assays for the in vitro diagnostics market, has established distribution partnerships for the ThunderBolt Automated Immunoassay Analyzer in 18 countries ...

Posted on: April 08, 2013
Developing a Genetic Hearing Screening for Newborns

Researchers at the Medical College of Wisconsin in Milwaukee, Wisc., have received a grant from the American Hearing Research Foundation to conduct a pilot study of genetic hearing screening for newborns at the Children's Hospital of Wisconsin to ensure ...

Posted on: April 07, 2013
Inherited Genetic Variations Have Major Impact on Childhood Leukemia Risk

Humans have between 20,000 and 25,000 genes that carry instructions for assembling the proteins that do the work of cells. Work led by St. Jude Children's Research Hospital found that children who inherit certain variations in four particular genes are ...

Posted on: April 06, 2013
Dr. Amber R. Phipps Named Vice President and Chief Operations Officer at American Esoteric Laboratories

American Esoteric Laboratories (AEL), the mid-south's largest independent provider of esoteric and clinical laboratory services, has announced that Dr. Amber R. Phipps has been named vice president and chief operations officer for the company. ...

Posted on: April 05, 2013
First Point-of-Care DNA Test Submitted for FDA Clearance by Spartan Bioscience

Spartan Bioscience, a point-of-care DNA testing company, has announced that it has submitted a 510(k) pre-market notification application to the FDA requesting regulatory clearance for its Spartan RX CYP2C19 genetic test.CYP2C19 is an enzyme that ...

Posted on: April 04, 2013
Genomic Health Presents International Studies Demonstrating Worldwide Adoption and Value of Oncotype DX Breast Cancer Test

Genomic Health presented results from 22 studies at the recent St. Gallen (Switzerland) International Breast Cancer Conference highlighting the impact of the Oncotype DX breast cancer test around the world.  New data continue to demonstrate the ...

Posted on: April 03, 2013
Breakthrough Gene Sequencing Test Improves Detection and Treatment of Cancer

The University of Washington and Seattle Cancer Care Alliance (SCCA) partnered to launch UW-OncoPlex,  an advanced gene sequencing test to help clinicians treat cancer. The new diagnostic tool is a significant milestone in the development of ...

Posted on: April 02, 2013
CD Diagnostics is To Be Featured in Episode of Health Heroes

CD Diagnostics will be featured in an upcoming episode of Health Heroes. Located in Wynnewood, PA, CD Diagnostics is a leader in joint fluid analysis. The company's scientific founder, Carl Deirmengian, MD, discovered the existence of unique genetic ...

Posted on: April 01, 2013
March 2013
University of Surrey Licenses Patented Use of EN2 Protein as a Diagnostic Biomarker for Prostate and Bladder Cancer to ZEUS ...

The University of Surrey, one of the UK's leading professional, scientific and technological universities, and ZEUS Scientific, a United States based global in vitro diagnostics company, have entered into an agreement that grants ZEUS Scientific a ...

Posted on: March 31, 2013
Westpak Offers New ASTM F1929-12 Dye Penetration Test Methods

As the medical industry demands more higher quality seals that can prevent harmful contaminant from entering the package, Westpak Inc.  now offers three dye penetration test methods.  These test methods are specified in the new revision of the ...

Posted on: March 30, 2013
Ventana and Biocare Medical Sign License Agreement to Aid in p63 Differential Diagnosis of Prostate Lesions

Ventana Medical Systems and Biocare Medical have entered into a non-exclusive license agreement to allow Biocare access to certain patents and materials related to p63 diagnostics in the research and IVD field. In parallel, Biocare and AsymmetRx have ...

Posted on: March 29, 2013
CVA and Cal-Chex Assays Add Instruments

Streck's CVA, an assayed linearity control kit used to determine the patient reportable range of 3-part and 5-part hematology instruments, is now assayed for the Beckman Coulter UniCel DxH 800, beginning with lot 3070.CVA establishes an instrument's ...

Posted on: March 28, 2013
Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies

Leica Biosystems and Synthon Biopharmaceuticals, a subsidiary of specialty pharmacompany Synthon, today announced an agreement to collaborate on the development andcommercialization of a companion diagnostic test using the Leica BOND system, paired ...

Posted on: March 27, 2013
African Society for Laboratory Medicine helps African Labs Leapfrog over Technical Obstacles

Since its inception in 2011, the African Society of Laboratory Medicine (ASLM) has focused on building capacity in African healthcare laboratories, recognizing that providing efficient and accurate diagnostic services is critical to patient health. To ...

Posted on: March 26, 2013
More Rapid Test for Group B Strep Successful

A more rapid laboratory test for pregnant women to detect potentially deadly Group B strep (GBS) has been successful at identifying GBS colonization in six and a half hours, according to the results of a study from The University of Texas Health Science ...

Posted on: March 25, 2013
American Esoteric Laboratories Enhances Women's Health Offerings

American Esoteric Laboratories (AEL), the mid-south's largest independent provider of esoteric and clinical laboratory services, announced that it has expanded its test offerings for women with the addition of the Trichomonas Amplified Probe test ...

Posted on: March 24, 2013
R. Rodney Howell, MD, Newborn Screening Pioneer, Honored

A geneticist and pediatrician who played a key role in developing the uniform panel of serious disorders for which nearly every baby in the United States now is tested has received the March of Dimes Col. Harland D. Sanders Lifetime Achievement Award in ...

Posted on: March 23, 2013
Pre-Employment Drug Test Positives Increase More Than 5%

Job candidates subject to pre-employment drug screening tested positive for illicit drugs at a greater rate in the first six months of 2012 than in all of 2011, according to Drug Testing Index (DTI) data released today by Quest Diagnostics, provider of ...

Posted on: March 22, 2013
ACMG Releases Highly-Anticipated Recommendations on Incidental Findings in Clinical Exome and Genome Sequencing

The American College of Medical Genetics and Genomics (ACMG) released the widely-anticipated "ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing" report at its 2013 Annual Clinical Genetics Meeting ...

Posted on: March 21, 2013
Researchers Discover How to Shutdown Lymphoma's Powerful Master Protein

The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex to target with a drug since ...

Posted on: March 20, 2013
Landmark Survey of Prostate Biopsies Shows Increased Cancer Detection with 10 to 12-core Biopsies

The findings of the largest reported study on prostate biopsies were released at the recent American Society of Clinical Oncology Genitourinary Cancers Symposium in Orlando. The research confirmed that cancer detection rates are enhanced when 10 to ...

Posted on: March 19, 2013
Merck and Luminex to Develop Companion Diagnostic to Support Investigational BACE Inhibitor Clinical Development Program for ...

Merck and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral ...

Posted on: March 19, 2013
PathCentral Launches Comprehensive Global Online Pathology Information Exchange

PathCentral, a technology-enabled company dedicated to the pathology community, recently unveiled the PathCentral Pathology Network at www.pathcentralpro.net -- a comprehensive online information exchange and digital consultation ...

Posted on: March 18, 2013
Early Detection of MS Treatment Complication May Improve Survival

The drug natalizumab is effective for treating multiple sclerosis (MS), but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML). A study released today that will be presented at ...

Posted on: March 17, 2013
Covaris Introduces a Novel FFPE DNA Extraction Kit

Covaris, Inc. introduced the single-tube FFPE DNA Extraction Kit at the 2013 Advances in Genome Biology and Technology (AGBT) meeting held recently in Marco Island, Fla. The kit provides an optimized reagent and protocol for high-yield DNA ...

Posted on: March 16, 2013
Discovery Could Indicate New Target for ALS Therapy

In a study featured in the journal Neuron, researchers funded by The ALS Association have discovered evidence of an unexpected cellular process in some people with amyotrophic lateral sclerosis (ALS). The results should allow researchers to better track ...

Posted on: March 15, 2013
Siemens Urinalysis System Delivers Wireless Connectivity and Enhanced Barcoding

With a recent software upgrade (V2.5/2.3.0.0) and new adaptor for its CLINITEK Status Connect System, Siemens Healthcare Diagnostics now offers hospitals and clinicians seamless wireless connectivity and improved barcoding capabilities for point-of-care ...

Posted on: March 15, 2013
Shiel Medical Laboratory's Oxidized LDL Triple Marker Test Uncovers Symptoms of Latent Heart Disease Better than Standard ...

The primary clinical laboratory test used by physicians to identify patients with coronary artery disease (CAD) fails to measure oxidized low-density lipoprotein (LDL), the plaque-specific protein directly involved in the disease process. A key study ...

Posted on: March 13, 2013
American Society for Clinical Pathology and the Association for Pathology Informatics Forge Alliance for Mutual Benefits

The American Society for Clinical Pathology (ASCP) and the Association for Pathology Informatics (API) signed a Memorandum of Understanding (MOU) effective March 8 to collaborate on education, advocacy, and membership strategies to the mutual benefit of ...

Posted on: March 12, 2013
BioFire Receives FDA Clearance for Updated FilmArray Respiratory Panel

BioFire Diagnostics Inc. announced today the FDA clearance of its updated FilmArray Respiratory Panel. The purpose of the updated panel is to improve the detection of Adenovirus.  Studies performed to support the clearance of the modified panel ...

Posted on: March 12, 2013
New Penn Medicine Blood Center to Unify Patient Care, Research, and Public Education Efforts for Blood Disorders

Penn Medicine will establish the Philadelphia region's first dedicated center for the treatment and research of blood diseases by combining the expertise of physicians who specialize in the care of blood disorder patients of all ages along with basic ...

Posted on: March 11, 2013
Two Studies Demonstrate Innovations in Next Generation Sequencing From Paraffin Tissue

Genomic Health Inc. announced the results of two studies demonstrating that DNA strand-of-origin information can help further refine the identification of prognostic biomarkers, and that tumor specific gene mutations can be effectively examined using ...

Posted on: March 11, 2013
Americord Offers Cord Blood Storage Price Incentive

Americord Registry announced that it would match any competitor's prices for cord blood banking and cord tissue banking. The matched pricing is part of numerous efforts the company has underway to simplify cord blood banking for parents interested in ...

Posted on: March 10, 2013
Variations in Four Genes Associated with an Increased Risk of Colorectal Cancer

An international research team co-led by cancer prevention researcher Ulrike "Riki" Peters, PhD, MPH, and biostatistician Hsu Li, PhD, at Fred Hutchinson Cancer Research Center has identified variations in four genes that are ...

Posted on: March 08, 2013
Genetic Variation Doubles Risk of Aortic Valve Calcification

Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic ...

Posted on: March 07, 2013
Quest Diagnostics Ranks No. 1 in Industry Category on FORTUNE's World's Most Admired Companies List

Quest Diagnostics, the world's leading provider of diagnostic information services, has been recognized in FORTUNE magazine's "World's Most Admired Companies" list as the No. 1 company in the healthcare industry category of "Pharmacy and Other ...

Posted on: March 06, 2013
CDC Sequestration Cuts Will Only Add to US Financial Problems, Say GlobalData Analysts

With the Centers for Disease Control and Prevention (CDC) expected to see its budget slashed by close to $450m, or about 8% of its total funding for FY2013 as part of the impending sequestration cuts, the agency's ability to protect individuals from ...

Posted on: March 05, 2013
Quest Diagnostics to Provide Nationwide Access to Natera's New Non-Invasive Prenatal Test

Quest Diagnostics, a diagnostic information services company, and Natera, an innovator in prenatal genetic testing, has announced that Quest Diagnostics will offer physicians access to Panorama, a new non-invasive prenatal test developed by ...

Posted on: March 04, 2013
Researchers Uncover New Findings on Genetic Risks of Chronic Inflammatory Disorder Behçet's Disease

Researchers don't know the exact cause of Behçet's disease, a chronic condition that leads to oral and genital sores and serious complications such as blindness, but new research brings better understanding to what makes some people more susceptible to ...

Posted on: March 03, 2013
Walgreens Tour Provides Free Tests to Underserved Communities

Walgreens has announced the Walgreens Way to Well Health Tour with AARP, continuing through 2013 will provide free preventative and early detection health services to some of the nation's most underserved communities.  Now through December, the tour ...

Posted on: March 02, 2013
AMA and McKesson Team Up to Bring Transparency and Clarity to Molecular Diagnostic Testing

The American Medical Association (AMA) and McKesson have entered into a licensing relationship to offer the healthcare system a consistent and transparent way to identify and track molecular diagnostic (MDx) tests. Under the ...

Posted on: March 01, 2013
February 2013
AB SCIEX Announces Company's First In Vitro Diagnostic Device

AB SCIEX, a leader in analytical technologies, has introduced the AB SCIEX API 3200MD and 3200MD QTRAP LC/MS/MS systems, two devices that can be used to analyze trace levels of multiple compounds in human samples for diagnostic ...

Posted on: February 28, 2013
AB SCIEX Announces Company's First In Vitro Diagnostic Device

AB SCIEX, a leader in analytical technologies, has introduced the AB SCIEX API 3200MD and 3200MD QTRAP LC/MS/MS systems, two devices that can be used to analyze trace levels of multiple compounds in human samples for diagnostic ...

Posted on: February 28, 2013
Quest Diagnostics to Sell HemoCue Business to Radiometer Medical ApS

Quest Diagnostics, a provider of diagnostic information services, announced that it has signed a definitive agreement to sell its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus ...

Posted on: February 27, 2013
Nanomix Initiates Clinical Testing of Point of Care IVD Cardiac Panel

Portable testing platform promises advances in rapid cardiac testing outside traditional laboratory settingsNanomix, a nanotechnology company focused on development of next generation point of care diagnostic tests to enable earlier and more accurate ...

Posted on: February 26, 2013
Abbott to Collaborate with Janssen and Pharmacyclics on CDx for Investigational Leukemia Therapy

Abbott has announced it will collaborate with Janssen Biotech Inc. and Pharmacyclics Inc. to explore the benefits of Abbott's proprietary FISH (fluorescence in situ hybridization) technology for use in developing a molecular companion diagnostic ...

Posted on: February 25, 2013
Study of Human Specimen Collections in the U.S. Offers First Look at Their Huge Diversity

The rise of the human genome project and of large-scale genetics studies have spurred a dramatic increase in the number of biobanks that collect, store and share human specimens (e.g., blood, solid tissues, hair) for research purposes. But until now, ...

Posted on: February 24, 2013
Health Care Providers May Be at Greater Risk of Flu Exposure Than Previously Thought

Some people with the flu emit more of the air-borne virus than others, suggesting that the current recommendations for infection control among health care providers may not be adequate, according to a new study from researchers at Wake Forest Baptist ...

Posted on: February 23, 2013
Government Mistrust Deters Older Adults From HIV Testing

One out of every four people living with HIV/AIDS is 50 or older, yet these older individuals are far more likely to be diagnosed when they are already in the later stages of infection. Such late diagnoses put their health, and the health of others, at ...

Posted on: February 22, 2013
Field Based Chemistry North America 2013 Set for May 14

Cresset, provider of chemistry software and services, announces that Field Based Chemistry North America 2013, a scientific meeting on the use of fields in the design and discovery of small molecules, will be held May 14 in Cambridge, Mass.The event is ...

Posted on: February 21, 2013
Phone and Mailed Interventions Significantly Increase Colorectal Cancer Screening Rates

A mailing or phone call to help patients get screened for colorectal cancer significantly increases their chances of actually getting tested, according to a study published in the January issue of Cancer Epidemiology, Biomarkers and ...

Posted on: February 20, 2013
High Blood Calcium Levels May Indicate Ovarian Cancer

A new study from Wake Forest Baptist Medical Center is the first to report that high blood calcium levels might predict of ovarian cancer, the most fatal of the gynecologic cancers.Lead author Gary G. Schwartz, Ph.D., a cancer epidemiologist at Wake ...

Posted on: February 19, 2013
Genetic Test Identifies Small but Deadly Lung Cancers

A novel genetic test can help identify small but aggressive lung tumors associated with poor survival, according to a study released today the recent 49th Annual Meeting of The Society of Thoracic Surgeons held at the Los Angeles Convention Center.Key ...

Posted on: February 18, 2013
Low Vitamin D Levels Linked to High Risk of Premenopausal Breast Cancer

A prospective study led by researchers from the University of California, San Diego School of Medicine has found that low serum vitamin D levels in the months preceding diagnosis may predict a high risk of premenopausal breast cancer.The study of blood ...

Posted on: February 17, 2013
Gene Sequencing Project Mines Data Once Considered 'Junk' for Clues About Cancer

Genome sequencing data once regarded as junk is now being used to gain important clues to help understand disease. The latest example comes from the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project, where ...

Posted on: February 16, 2013
Personal Epigenetic "Signatures" Found Consistent in Prostate Cancer Patients' Metastases

In a genome-wide analysis of 13 metastatic prostate cancers, scientists at the Johns Hopkins Kimmel Cancer Center found consistent epigenetic "signatures" across all metastatic tumors in each patient. The discovery of the stable, epigenetic "marks" that ...

Posted on: February 15, 2013
Center Receives Grant to Develop Blood Test for MCI

The Biomarker Discovery Center at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine has been awarded a three-year, $799,800 grant from the Osteopathic Heritage Foundation to develop a blood test that can diagnose mild ...

Posted on: February 14, 2013
Study Shows Promising Results for Diagnostic Tests that Help to Better Evaluate Potential Heart Attacks

Acute chest pain is one of the most common reasons people seek emergency care, and time is a critical factor in diagnosing and treating people who may be having a heart attack. The latest generation of diagnostic tests in development is expected to ...

Posted on: February 13, 2013
Mayo Clinic and SV Bio Enter Strategic Relationship on Genome Diagnostics and Interpretation

Mayo Clinic and Silicon Valley Biosystems have announced a strategic collaboration for whole genome diagnostics and interpretation at the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories. This strategic collaboration ...

Posted on: February 12, 2013
Kindstar Global First to Tap PathCentral's New Pathology Network

PathCentral has announced the roll-out of the PathCentral Pathology Network, an online professional pathology network that will enable diagnostics company Kindstar Global to access U.S. pathologists and facilitate pathology ...

Posted on: February 11, 2013
Rapid Diagnostic Test for Leprosy Announced

IDRI (Infectious Disease Research Institute), in conjunction with OrangeLife, a Brazilian diagnostic company, has announced the registration of a rapid diagnostic test for leprosy, offering new hope for early diagnosis and treatment. The test was ...

Posted on: February 10, 2013
Great Basin Corporation Acquires 9.5 million in Series B Funding

Great Basin Corporation, a molecular diagnostics company that develops sample-to-result solutions, has recently gained $9.5 billion in second stage - or "Series B - funding. The privately held company is working towards more accurate and information-rich ...

Posted on: February 09, 2013
DiaSorin Inc. Receives Clearance for LIAISON Direct Renin Assay

DiaSorin Inc. has received FDA clearance for their LIAISON Direct Renin immunoassay to aid in the diagnosis and treatment of certain types of hypertension."Hypertension affects approximately 67 million US adults and is the major contributor to ...

Posted on: February 08, 2013
Mobile Device Uses Cloud to Speed Up Diagnostic Testing for HIV and More

Samuel K. Sia, associate professor of biomedical engineering at Columbia Engineering, has taken his innovative lab-on-a-chip and developed a way to not only check a patient's HIV status anywhere in the world with just a finger prick, but also ...

Posted on: February 07, 2013
New Test Predicted Presence of Harmful BRCA Mutations

A new multiple gene expression profile test was able to predict the presence of harmful BRCA1 or BRCA2 mutations in otherwise healthy women carrying the mutations, according to data published inCancer Prevention Research, a journal of the American ...

Posted on: February 07, 2013
DA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer

The FDA has granted the new automated, multifunctional ESA615 Electrical Safety Analyzer 510(k) clearance. Now medical device quality and safety professionals can test to the newest safety standards in minutes using this all-in-one automated test ...

Posted on: February 06, 2013
National Quality Forum Endorses 14 Infectious Disease Measures

The Board of Directors of the National Quality Forum (NQF), a "voluntary consensus standard setting organization," have sanctioned 14 infectious disease quality measures. The quality measures include the vaccination and treatment of hepatitis C, the STD ...

Posted on: February 05, 2013
Education Platform from Immucor Now Available for the Blood Banking Community

Immucor Inc. recently launched a customer education platform called the Lab Education and Resource Network (LEARN), allowing for professionals to connect with each other online.  LEARN provides an interactive education for blood bank workers through ...

Posted on: February 04, 2013
Unrecorded Mutations Detected in Triple Negative Breast Cancer with the Use of Whole Genome Sequencing

A study titled "Genome and transcriptome sequencing in prospective triple negative breast cancer uncovers therapeutic vulnerabilities" published in Molecular Cancer Therapeutics, noted newly discovered mutations in metastatic triple negative breast ...

Posted on: February 03, 2013
Team Finds Gene That Promotes Drug Resistance in Cancer

Scientists from the University of Iowa and Brigham Young University (BYU) have identified a gene that may be a target for overcoming drug resistance in cancer. The finding could not only improve prognostic and diagnostic tools for evaluating cancer and ...

Posted on: February 02, 2013
Fewer Minorities Get Screened for Colorectal Cancer

A new study conducted in the Center for Health Policy at the University of Nebraska Medical Center College of Public Health has determined that racial and ethnic minorities are less likely to be screened for colorectal cancer in the United States.The ...

Posted on: February 01, 2013
January 2013
Luminex Receives FDA Clearance for Gastrointestinal Pathogen Infectious Disease Diagnostic

Luminex Corporation has received FDA clearance for its xTAG Gastrointestinal Pathogen Panel (GPP), the first comprehensive molecular diagnostic assay that tests for greater than 90% of bacterial, viral, and parasitic causes of infectious ...

Posted on: January 31, 2013
New PTFE Plate-Sealing Tape with Pattern Adhesive

Sarstedt introduces a premium PTFE 96-well plate sealing tape with pattern adhesive suitable for many applications including PCR, qPCR, auto-sampling, and storage. PTFE offers chemical compatibility and is optically clear with virtually no ...

Posted on: January 30, 2013
QIAGEN Submits Companion Diagnostic to FDA to Guide Treatment Decisions for New Investigational Lung Cancer Compound

QIAGEN has announced submission of its therascreen EGFR RGQ PCR Kit (therascreen EGFR test) to the FDA as a proposed companion diagnostic to guide treatment with afatinib, a new investigational oncology compound developed by Boehringer Ingelheim. ...

Posted on: January 30, 2013
Saliva Gland Test for Parkinson's Disease?

New research suggests that testing a portion of a person's saliva gland may be a way to diagnose Parkinson's disease. The study will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013."There is ...

Posted on: January 29, 2013
Investigators Discover New Gene That Affects Clearance of Hepatitis C Virus

Scientists have discovered a gene that interferes with the clearance of hepatitis C virus infection. They also identified an inherited variant within this gene, Interferon Lambda 4 (IFNL4), that predicts how people respond to treatment for hepatitis C ...

Posted on: January 28, 2013
Study Shows Promise of Molecular Screening for Gynecologic Cancers,

A new study that proposes a three-in-one test for gynecologic cancers - combining a traditional Pap smear for cervical cancer with a DNA test for gene mutations linked to endometrial and ovarian cancer - underscores the promise of molecular screening for ...

Posted on: January 27, 2013
Ariosa Diagnostics Enters 2013 with New Offering and Global Expansion

Ariosa Diagnostics, provider of the Harmony Prenatal Test, recently announced plans to expand the indications for the Harmony test and broaden access into new, significant global markets.The Harmony test analyzes cell-free DNA circulating in maternal ...

Posted on: January 26, 2013
Study Suggests Tests Routinely Done on Patients with Microscopic Blood in Urine Can Be Avoided

The presence of microscopic hematuria - blood found in urine that can't be seen by the naked eye -- does not necessarily indicate the presence of cancer, according to a Kaiser Permanente Southern California study published in the journal Mayo Clinic ...

Posted on: January 25, 2013
VolitionRx Announces Collaboration with Wales Cancer Bank

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that it will commence a large internal clinical study for its Nucleosomics diagnostic products this month. This trial is being undertaken in ...

Posted on: January 24, 2013
Researchers Foresee New Treatments and Diagnostics for Deadly Fibrotic Diseases of the Lung, Liver, and Kidney

A team of scientists has developed a playbook for ending the devastating impact of fibrotic diseases of the liver, lung, kidney, and other organs, which are responsible for as many as 45 percent of all deaths in the industrialized world. Despite the ...

Posted on: January 23, 2013
OriGene Publishes Paper on Proteome Platform for Antibody Specificity Test

OriGene Technologies, a leader in producing genome wide products for research and diagnostic applications, has brought the antibody field one step closer to identifying and developing ultra-specific monoclonal antibodies. Specificity of antibodies for ...

Posted on: January 22, 2013
Discovery Makes Early Diagnosis of Sjogren's Syndrome a Reality for the First Time

Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics Inc. The ...

Posted on: January 21, 2013
Biomarkers Could Give Early Warning of Late Heart Transplant Rejection

Researchers at Boston Children's Hospital have found a combination of biomarkers related to blood vessel and tissue injury that, when measured together, could signal when a transplanted heart is becoming damaged to the point of failure, a process that is ...

Posted on: January 20, 2013
New Screening Approach Identified Potential Drug Combinations for Difficult-to-Treat Forms of Melanoma

A novel approach to identifying potential anticancer drug combinations revealed that pairing cholesterol-reducing drugs called statins with cyclin-dependent kinase inhibitors might provide an effective approach to treating intractable melanomas driven by ...

Posted on: January 19, 2013
Additional Evidence That Vitamin D Reduces the Risk of Developing Autism

A study published online in the peer-reviewed journal Dermato-Endocrinology found additional evidence that vitamin D reduces the risk of developing autism. The study examined the variation of autism prevalence by state for those aged 6-17 years ...

Posted on: January 18, 2013
Gene Variants Affect Pain Susceptibility in Children

At least two common gene variants are linked to "clinically meaningful" differences in pain scores in children after major surgery, reports a study in the January issue of Anesthesia & Analgesia, official journal of the International Anesthesia ...

Posted on: January 17, 2013
New Abbott Assay Measures Testosterone Levels to Help Diagnose Related Conditions in Both Men and Women

Testosterone is an important androgen hormone in the health and well-being of men and women.Testosterone levels are associated with sexual development, libido, protection against osteoporosis, and cardiovascular health. In men,insufficient ...

Posted on: January 16, 2013
Researchers Develop Tool to Evaluate Genome Sequencing Method

Advances in bio-technologies and computer software have helped make genome sequencing much more common than in the past. But still in question are both the accuracy of different sequencing methods and the best ways to evaluate these efforts. Now, ...

Posted on: January 15, 2013
Sartorius Stedim Biotech Expands Portfolio by Adding Cell Culture Media

Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, has announced a substantial expansion of its product array in the cell culture range. The company signed a cooperation agreement with the Swiss-based life ...

Posted on: January 14, 2013
Loyola Hospital Videos Top 100,000 Views on YouTube

More than 100,000 viewers have now watched Loyola University Health System videos on YouTube's LoyolaHealth channel. Loyola reached the milestone Dec. 11, 2012. And Loyola's Facebook page now has more than 5,000 friends.The LoyolaHealth channel on ...

Posted on: January 12, 2013
A Rapid Test for Fungus That Caused Injection Deaths Is Announced

A rapid detection test forExserhilum rostratum, the fungus primarily responsible for 39 deaths among patients injected last year with a contaminated steroid medication, has been developed by a research team led by David S. Perlin, PhD, Executive Director ...

Posted on: January 11, 2013
Study Finds Genetic Variation That Could Help Predict Mortality in Patients Suffering Sepsis

A study in the January  issue of Anesthesiology offers evidence that variations in what is called the NFKB gene could play an important role in helping to determine the survival rate of patients who acquire sepsis, the leading cause of ...

Posted on: January 11, 2013
Discovery of Genetic Basis for Dystonia Brings Opportunity for Development of Diagnostic Tests, Novel Treatments

Scientists from Beth Israel Medical Center and the Icahn School of Medicine at Mount Sinai have announced the discovery of a novel gene for primary torsion dystonia, a debilitating neurological disorder estimated to affect no fewer than 300,000 people in ...

Posted on: January 10, 2013
Boston Children's Hospital and Life Technologies Launch Claritas Genomics

Boston Children's Hospital has partnered with Life Technologies Corporation to launch Claritas Genomics, a new company formed to develop next-generation, genetic and genomics-based diagnostic testing solutions. The venture combines advanced ...

Posted on: January 09, 2013
Breakthrough Research in DNA Mutation Analysis Could Lead to Earlier Diagnosis and More Tools for Personalized Treatment for ...

New research appearing online in Clinical Chemistry, the journal of AACC, shows that the analysis of DNA mutations in patients with cancer can be done without surgery. This paper by Chan et al. shows that the plasma of cancer patients also carries ...

Posted on: January 08, 2013
Study Is First to Find Significant Link Between Sleepiness and Vitamin D

A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor.Results show that in patients with normal vitamin D levels, progressively higher levels of daytime ...

Posted on: January 08, 2013
Three New Representatives Elected to the SLAS Board of Directors

Members of the Society for Laboratory Automation and Screening (SLAS) elected three new representatives to serve on the SLAS Board of Directors for three-year terms effective Jan. 1, 2013. Eight outstanding candidates were presented to the SLAS ...

Posted on: January 07, 2013
Proteins Found in Urine May Enable Diagnosis of Kawasaki Disease

A set of proteins detected in urine by researchers at Boston Children's Hospital may prove to be the first biomarkers for Kawasaki disease, an uncommon but increasingly prevalent disease which causes inflammation of blood vessels that can lead to ...

Posted on: January 06, 2013
Roche's Mycoplasma PCR Test Accepted by FDA, Reduces Time for

Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the use of its PCR based mycoplasma detection test MycoTOOL for release testing of one of Roche's biological products. It is the first commercially available mycoplasma PCR ...

Posted on: January 05, 2013
DioGenix Raises $1.5 Million for Novel Molecular Diagnostic for Multiple Sclerosis

Molecular diagnostics company DioGenix Inc. recently announced it raised $1.5 million in Series B financing. Existing investors including life sciences fund Nerveda LLC participated in the round to support a prospective, multi-site clinical trial to ...

Posted on: January 04, 2013
Quest Diagnostics Acquires UMass Memorial's Clinical and Anatomic Pathology Outreach Labs

Quest Diagnostics, the world's leading provider of diagnostic information services, announced it has completed its acquisition of the Worcester-based clinical outreach laboratory business of UMass Memorial Medical Center, a member of UMass Memorial ...

Posted on: January 03, 2013
Cubis Q-Apps Supports Both Common and Customized Weighing Processes

Many laboratories in the pharmaceutical industry rely on computerized systems for management of samples and lab analysis orders. Analytical systems, such as chromatographs and spectrometers, are often directly connected to such laboratory information ...

Posted on: January 02, 2013
New Category I CPT Codes and Payment Rates for Circulating Tumor Cell Testing Effective Today

Veridex, LLC today announced that new Category I Current Procedural Technology (CPT) codes for circulating tumor cell (CTC) testing go into effect in the United States on today, Jan. 1, 2013.  CPT codes are assigned by the American Medical ...

Posted on: January 01, 2013
December 2012
NeoGenomics Launches FISH Test for Surveillance and Diagnosis of High Grade Dysplasia/Esophageal Cancer

NeoGenomics, a provider of cancer-focused genetic testing services, announced today it has validated and launched a laboratory developed fluorescent in situ fybridization (FISH) assay for the surveillance of patients with Barrett's Esophagus (BE). The ...

Posted on: December 31, 2012
Meridian Bioscience Successfully Completes Beta Trials for Two New illumigene Tests

Meridian Bioscience announced that it has successfully completed beta trials for two new illumigene molecular amplification tests. These assays are designed to specifically detect the DNA of Chlamydia ...

Posted on: December 30, 2012
PathCentral Sells Diagnostic Laboratory to Ascend Clinical

PathCentral, a technology-enabled company dedicated to the success of the pathology community, recently  announced the sale of its diagnostic laboratory business to Ascend Clinical, the end-stage renal disease (ESRD) laboratory testing leader for ...

Posted on: December 29, 2012
Rapid Genome Test for Infants Named One of TIME's Top Medical Breakthroughs of 2012

A rapid whole genome sequencing approach developed by the Center for Pediatric Genomic Medicine at Children's Mercy Hospitals and Clinics in Kansas City, was named one of TIME magazine's Top 10 Medical Breakthroughs of 2012.In the October issue of the ...

Posted on: December 28, 2012
Study Shows Promising Results for Tests That Can Help Doctors Better Evaluate Potential Heart Attacks

Acute chest pain is one of the most common reasons people seek emergency care, and time is a critical factor in diagnosing and treating people who may be having a heart attack. The latest generation of diagnostic tests in development is expected to ...

Posted on: December 27, 2012
Wisconsin Bloodcenter Announces Comprehensive Hemophilia Genetics Testing

Fresh from the BloodCenter of Wisconsin diagnostics lab is an expansion in their genetic testing menu for hemophilia.  The new, comprehensive approach identifies the genetic abnormality in over 95 percent of all hemophilia patients.  The ...

Posted on: December 26, 2012
Leukemia Patients Remain in Remission More Than Two Years After Receiving Genetically Engineered T Cell Therapy

Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the therapy, which was pioneered by scientists in the Perelman School of Medicine at ...

Posted on: December 25, 2012
Computers 'Taught' To ID Regulating Gene Sequences

Johns Hopkins researchers have succeeded in teaching computers how to identify commonalities in DNA sequences known to regulate gene activity, and to then use those commonalities to predict other regulatory regions throughout the genome. The tool is ...

Posted on: December 24, 2012
ClonoSEQ Assay Detects Minimal Residual Disease in Blood-based Cancers

Adaptive Biotechnologies, a leading provider of next-generation sequencing assays for the adaptive immune system, has introduced clonoSEQ, a clinical assay to measure minimal residual disease (MRD) in a range of blood-based cancers that is significantly ...

Posted on: December 23, 2012
Devicor Announces FDA Approves Mammotome revolve Biopsy System

Devicor Medical Products recently announced  that the FDA has approved Mammotome revolve, a dual vacuum-assisted biopsy system, for use on patients.Mammotome revolve is the next generation biopsy system, leveraging the clinician- and ...

Posted on: December 22, 2012
Roche 454 Sequencing Systems Resolve Genetic Mutations in Over 4,000 Blood Cancer Cases

At the American Society of Hematology Meeting (ASH) earlier this month, Roche announced the presentation of results from the large scale study IRON-II through an international research consortium. Based on next generation 454 Sequencing Systems from ...

Posted on: December 21, 2012
A Better Early Blood Test for Autism

Researchers at Boston Children's Hospital have developed a blood test for autism spectrum disorders (ASDs) that outperforms existing genetic tests, while presenting evidence that abnormal immunologic activity affecting brain development may help explain ...

Posted on: December 20, 2012
New Gene-Sequencing Tools Offer Clues to Highest-Risk Form of a Childhood Cancer

Using powerful gene-analysis tools, researchers have discovered mutations in two related genes, ARID1A and ARID1B, that are involved in the most aggressive form of the childhood cancer neuroblastoma. While these findings do not immediately improve ...

Posted on: December 19, 2012
Better Blood Transfusions for Preterm Babies

Results of new research from the University of Adelaide are a promising step forward in helping to improve the quality of life-saving blood transfusions for preterm babies, by reducing the likelihood of adverse inflammatory responses to the ...

Posted on: December 18, 2012
CARD and Lineagen Offer Genetic Testing, Counseling for Children on Autism Spectrum

Center for Autism and Related Disorders (CARD) and Lineagen Inc. launched a new clinical partnership this month to offer Lineagen's FirstStep(Dx) genetic test to patients and their families. FirstStep(Dx) is a whole-genome genetic test customized with ...

Posted on: December 17, 2012
OncoHealth's HPV E6/E7 Assays Help Differentiate Cervical Disease From Clinically Insignificant HPV Infections

OncoHealth Corporation, a protein biomarker diagnostics company, has announced three new studies demonstrating the effectiveness of assays using its proprietary HPV E6 and E7 biomarkers to distinguish clinically meaningful cervical disease from ...

Posted on: December 16, 2012
Texas Now Screening Newborns for SCID

Texas Department of State Health Services (DSHS) added severe combined immunodeficiency (SCID) to the state's newborn screening panel on Dec. 1. The Immune Deficiency Foundation (IDF), the national patient organization for persons with primary ...

Posted on: December 15, 2012
Genome-Scale Study ID's Hundreds of Drug Targets for Huntington's

Scientists searching for ways to develop treatments for Huntington's disease (HD) just got a roadmap that could dramatically speed their discovery process. Researchers at the Buck Institute have used RNA interference (RNAi) technology to identify ...

Posted on: December 14, 2012
Short DNA Strands May be Key to Understanding Human Cognition and Diseases

Short snippets of DNA found in human brain tissue provide new insight into human cognitive function and risk for developing certain neurological diseases, according to researchers from the Departments of Psychiatry and Neuroscience at Mount Sinai School ...

Posted on: December 13, 2012
New Antibodies Streamline Flow Cytometry Research

Beckman Coulter Life Sciences has teamed with Trillium Diagnostics LCC in the production of 14 new human monoclonal antibodies.  The mutually beneficial partnership allows for broadened impact in each company's respective markets and provides ...

Posted on: December 12, 2012
QIAGEN Expands Access to HPV Testing in Low-resource Countries

QIAGEN has announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform. The careHPV Test is the first molecular diagnostic to screen for high risk human papillomavirus (HPV) designed for ...

Posted on: December 11, 2012
Clinical Study Shows Positive Performance of OVA1, Vermillion's Ovarian Cancer Test

Gynecologic Oncology, the prestigious medical journal of the Society for Gynecologic Oncology, has published the second prospective clinical study of OVA1® which demonstrated the positive performance of the multi-biomarker test in the triage of ...

Posted on: December 10, 2012
Clinical Study Supports Prognostic Utility of Saliva-Based TeloTest

Telome Health Inc., developer of the TeloTest diagnostic test that measures average telomere length, announces the planned launch of the saliva-based TeloTest in the first quarter of 2013. Related telomere tests, including percentage of short telomeres, ...

Posted on: December 09, 2012
BioNeutral Receives Positive Testing Results From Global Independent Laboratory For Its Ygiene Sterilant Against Anthrax Spores

BioNeutral Group, a specialty life science technology based company announced  that it has received positive test results from a global laboratory which is the world's largest private, independent research and development organization for its Ygiene ...

Posted on: December 08, 2012
Researchers Show Vitamin D- Type 1 Diabetes Link

A study led by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes. The six-year study of blood levels of nearly 2,000 individuals ...

Posted on: December 07, 2012
New Prenatal Test, Microarray, Proposed as Standard of Care

A large, multi-center clinical trial led by researchers from Columbia University Medical Center (CUMC) shows that a new genetic test resulted in significantly more clinically relevant information than the current standard method of prenatal testing. The ...

Posted on: December 06, 2012
Study Indicates Breast Cancer Diagnosis Is More Accurate with New Genomic Tests

The latest generation of genomic tests for breast cancer can improve physicians' ability to diagnose the disease and more precisely tailor each patient's treatment, according to a study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer ...

Posted on: December 06, 2012
HTG Molecular Diagnostics and PROOF Centre Partner to Commercialize COPD Prognostic Test

Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and HTG Molecular Diagnostics have finalized a  license agreement that provides HTG Molecular Diagnostics exclusive rights to commercialize PROOF Centre-developed gene ...

Posted on: December 04, 2012
Informatics and Bioimaging Center Combines Resources, Expertise

A new center that combines advanced computing resources at the University of Maryland, College Park (UMD) with clinical data and biomedical expertise at the University of Maryland, Baltimore (UMB) could soon revolutionize the efficiency and effectiveness ...

Posted on: December 03, 2012
New Gene-Sequencing Tools Offer Clues to Highest-Risk Form of a Childhood Cancer

Using powerful gene-analysis tools, researchers have discovered mutations in two related genes, ARID1A and ARID1B, that are involved in the most aggressive form of the childhood cancer neuroblastoma. While these findings do not immediately improve ...

Posted on: December 02, 2012
NF1 Breast Cancer Patients Require Additional Screening

New Johns Hopkins research showing a more than four-fold increase in the incidence of breast cancer in women with neurofibromatosis-1 (NF1) adds to growing evidence that women with this rare genetic disorder may benefit from early breast cancer screening ...

Posted on: December 01, 2012
November 2012
Study Finds Blood Lactate and Lactate Clearance Important Prognostic Variables for Mortality in Trauma Patients

Early after trauma, changes in blood lactate over time, defined as lactate clearance, provide additional information predicting mortality in trauma patients according to a study from the December issue of Anesthesiology. Researchers in Paris ...

Posted on: November 30, 2012
Abacus Diagnostica Receives CE Mark for its Rapid Direct PCR Test for Toxigenic C. Difficile

Abacus Diagnostica Ltd. announced that it has received the CE mark for its GenomEra C. difficile assay for the detection of toxin-producing Clostridium difficile directly from stool samples. C. difficileis the leading cause of infectiousnosocomial ...

Posted on: November 29, 2012
Johns Hopkins Scientists Pair Blood Test and Gene Sequencing to Detect Cancer

Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find ...

Posted on: November 28, 2012
Protein Test Is First to Predict Rate of Progression in Lou Gehrig's Disease

A novel test that measures proteins from nerve damage that are deposited in blood and spinal fluid reveals the rate of progression of amyotrophic lateral sclerosis (ALS) in patients, according to researchers from Mayo Clinic's campus in ...

Posted on: November 27, 2012
Edith Sanford Breast Cancer Foundation and Scripps Research Institute Partner To Advance Genomic Breast Cancer Research

The Edith Sanford Breast Cancer Foundation and The Scripps Research Institute (TSRI) announced an interdisciplinary collaboration that will lay the groundwork for significant advancements in personalized breast cancer treatment and care.Edith Sanford ...

Posted on: November 26, 2012
National Summit on HIV and Viral Hepatitis to Focus on Accelerating HIV/Hepatitis C Testing

 At a time when the prevalence of HIV among some Americans rivals parts of sub-Saharan Africa and recorded deaths from chronic hepatitis C infection are steadily increasing, the Forum for Collaborative HIV Research will convene its 2012 National ...

Posted on: November 25, 2012
Fungitell Assay Assists in Diagnosis of Invasive Fungal Infections

The Fungitell assay, manufactured by Associates of Cape Cod Inc. (ACC), is an FDA-cleared, highly sensitive, rapid diagnostic test that detects (1,3)-b-D-glucan in blood serum. This assay is intended for use as a diagnostic aid in clinical situations ...

Posted on: November 24, 2012
Gene Sequencing Project Identifies Abnormal Gene that Launches Rare Childhood Leukemia

Research led by the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project has identified a fusion gene responsible for almost 30 percent of a rare subtype of childhood leukemia with an extremely poor prognosis.The ...

Posted on: November 23, 2012
 

View the Latest from ADVANCE

 

Search Jobs

Go
 
 
 
 
http://promotions.advanceweb.com/CC/National-Hospital-Week-May.aspx